Skip to content

Developing a Self-Management Program for People With Depression and Chronic Medical Illness

Self-Management of Depression and Medical Illness

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00523029
Enrollment
104
Registered
2007-08-30
Start date
2006-02-28
Completion date
2008-06-30
Last updated
2013-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Self-management programs, Chronic medical illness

Brief summary

This study seeks to adapt an existing chronic disease self-management program for people with both chronic medical illness and depression.

Detailed description

Depression is a common but serious disorder that affects millions of people every year. Depression can severely impact people's lives, causing them to often feel sad and hopeless as well as affecting their sleep patterns, concentration, and energy levels. Treatment typically includes a combination of antidepressant medication and talk therapy. This study will evaluate the effectiveness of an adapted group education program typically used for chronic medical illness in improving the health status, health behaviors, and use of health care services among people with depression and a chronic illness. Participants in this open-label study will attend a group education program used to manage chronic medical illness. Group sessions will be held for 2.5 hours, once a week, for 6 weeks. Group leaders, also suffering from a chronic medical condition, will lead discussions based on the following topics: nutrition; exercise; appropriate use of medications; ways to communicate effectively with family, friends, and health care professionals; and how to make informed treatment decisions. Participants will also complete two surveys: one at the beginning of the study and one at the end. The first survey will ask basic questions related to participants' health status and any feelings of stress, anxiety, or sadness. The second survey will include a brief interview that will require participants to describe their experience in the group sessions and to suggest ways of improving the program to better accommodate people with depression and chronic illness. Responses to questions will be used to enhance the effectiveness of the group education program for treating people with both depression and a chronic medical condition.

Interventions

Chronic disease self-management is a 6-week group program that teaches participants how to manage their chronic medical illness. Group leaders, also suffering from a chronic medical condition, will lead discussions based on the following topics: nutrition; exercise; appropriate use of medications; ways to communicate effectively with family, friends, and health care professionals; and how to make informed treatment decisions.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Southern California
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

for Patients: * Currently attending the Edward R. Roybal Comprehensive Health Center or the LAC+USC Outpatient Department for primary care * English- or Spanish-speaking * Screens positive for major depressive disorder or minor depression based on the PRIME MD PHQ-9 * Suffers from a chronic medical illness (e.g., lung disease, asthma, emphysema or trouble breathing; heart disease or heart problems; high blood sugar or diabetes; arthritis or rheumatism) Inclusion Criteria for Group Leaders: * Prior experience facilitating a chronic disease self-management program within 6 to 9 months of study entry (including the groups held at Roybal Comprehensive Health Center)

Exclusion criteria

for Patients: * Acutely suicidal * Screens positive for bipolar disorder, psychotic disorder, or cognitive impairment disorder * History of alcohol or drug abuse

Design outcomes

Primary

MeasureTime frame
PRIME-MD Patient Health Questionnaire (PHQ-9)Measured at Week 8
Qualitative interviews of participants and leadersMeasured at Week 8
Post-intervention assessments, including self-efficacy, health behaviors, health status, and service utilizationMeasured at Week 8

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026